Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Type 2 Diabetes
Interventions: dietary fiber, HFHC meal; Dietary Supplement · Other
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Overweight
Interventions: Challenge!; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 11 Years to 16 Years
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity, Morbid, Bariatric Surgery Candidate
Interventions: Surgery; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 75 Years
Enrollment: 9,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Infant Obesity, Parenting, Feeding Behavior
Interventions: Responsive Feeding Training; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 3 Months to 9 Months
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Gestational Weight Gain
Interventions: Lifestyle Intervention; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 1,335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 4
States / cities: Oakland, California • Redwood City, California • San Francisco, California + 1 more

Conditions: Overweight, Obesity
Interventions: NNC0662-0419; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Cypress, California

Conditions: Body Fat Disorder
Interventions: The Zeltiq System; Device
Lead sponsor: Zeltiq Aesthetics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Overweight, Obesity
Interventions: NNC0247-0829, Placebo (NNC0247-0829); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Bone Development
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 9 Years to 12 Years · Female only
Enrollment: 358 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Obesity, Childhood
Interventions: Produce prescription program, Standard of care; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 5 Years to 12 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: Whey Protein, Combined Resistance and High-Intensity Interval training, Casein Protein; Other
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Adolescent Overweight, Adolescent Obesity, Sleep, Eating Behaviors, Dietary Intake
Interventions: Lifestyle Modification and Sleep Intervention; Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 14 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Diabetes Mellitus, Type 2
Interventions: Fit 24; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 14 Years to 16 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity, Overweight
Interventions: Underfeeding diet, Weight maintaining diet; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Obesity, Insulin Resistance, Obesity in Diabetes, Nutritional and Metabolic Diseases, Hyperlipidemia, Hyperglycemia, Cardiovascular Diseases
Interventions: Placebo-Control, Low-Dose Vitamin K2 (menaquinone-7; 45-mcg/d), High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d); Dietary Supplement
Lead sponsor: Augusta University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Obesity
Interventions: DMAC, CMAC; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: Phentermine-Topiramate Extended Release, Placebo, Online support system; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity
Interventions: beta3-adrenergic receptor agonist; Drug
Lead sponsor: Aaron Cypess; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: Reference naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets), Test naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets); Drug
Lead sponsor: Orexigen Therapeutics, Inc; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Type 2 Diabetes
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 12 Years to 18 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 2 Diabetes, Obesity
Interventions: Program ENERGY, comparison; Behavioral · Other
Lead sponsor: Colorado State University; Other
Eligibility: 6 Years to 13 Years
Enrollment: 2,909 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2011
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Obesity
Interventions: Sitagliptin, Pegvisomant, Placebo, L-NMMA, Exendin 9-39; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Maternal Obesity Syndrome
Interventions: cross-sectional; Other
Lead sponsor: University of Wyoming; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Laramie, Wyoming

Conditions: Obesity, Insulin Resistance, Insulin Sensitivity, Beta-Cell Dysfunction, Prediabetes
Interventions: Placebo, Low-Dose Vitamin K2 Supplement (menaquinone-7; 90-mcg/d), High-Dose Vitamin K2 Supplement (menaquinone-7; 180-mcg/d); Dietary Supplement
Lead sponsor: Augusta University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Augusta, Georgia

Search by objective public record fields.

Anti-inflammatory Effects of the Fiber

Challenge!, a Health Promotion/ Obesity Prevention Program for Teens

Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery

Learning to Love Mealtime Together

A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity

Pilot Study on the Submental Area

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

Soft Tissue and Bone Development in Young Girls

Brighter Bites & University of Texas Physicians Produce Rx Extension: Evaluating the Effectiveness of a Prospective Clinical Nutrition Study With Produce Prescriptions

Nighttime Macronutrient Choice and Combined Resistance and High-intensity Interval Training

Improving Sleep, Decision-Making, and Eating in Adolescents With Obesity

Fit 24 Technology Intervention YOUTH

Predicting Adherence to a Heart-Healthy Diet in Lean and Obese Individuals

Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).

Obesity and Diabetes Prevention Through Science Enrichment

Effect of DPP4 Inhibition on Growth Hormone Secretion

Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk

Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)